From Ideas To Impact™

We manage commercialisation of inventions, intellectual property and technology transfer to convert research to positive societal impact.

Two persons adjusting something on a robot
take part IES

Want to become a business developer or mentor? Apply here! (external link)

We are constantly looking for talent and enthusiastic people to join commercialising our innovation projects or mentoring the project teams.

submit inv disco

Take part of our survey (external link)

The purpose of the survey is to map the innovation potential in Aalto University in relation to both the researchers' interest to commercialize/productize their research results and the possibilities for utilization of research results. The survey is organized by Aalto University Innovation Services.

IPR guide

IPR guide (external link)

Innovation Services’ Researchers Practical Guide to Intellectual Property offers practical information about intellectual property rights, such as patents and copyrights.

News

future of vertical farming
Cooperation Published:

NORDIC TOP 50 IMPACT COMPANIES - 2022

Our startup Vacuum insulation Solutions Oy was selected to the list of Nordic Top 50 Impact Companies 2022.
NBG
Cooperation Published:

OPEN APPLICATION: Business Developers for future deep-tech startups needed

Would you like to grow a deep tech startup? Are you excited about creating an international business from deep technology?  Apply now (open application)
deepfrst
Cooperation Published:

DeepFRST aims for initiating a startup

How can forest owners reconcile timber revenues, carbon sinks, and biodiversity?
fepod
Cooperation Published:

Portable and quick analytics tool can revolutionise the pain killer diagnostics market

Fepod Oy Ltd, an Aalto University based start-up, has developed an analysis tool that allows healthcare professionals to measure the concentration of paracetamol, opioids and other painkillers real concentration in a single drop of blood. The company has just received €750 000 in seed funding from Almaral Oy to continue clinical trials and develop sensor technology and a software platform.

Follow us